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ABSTRACT 
CLINICAL RISK FACTORS FOR SUBSTANCE ABUSE: THE POTENTIAL EFFECTS ON 
TREATMENT OUTCOMES 
Sydney Danielle Hurt, B.S.  
Western Carolina University (January 2016) 
Director: Dr. Kia Asberg 
 
Alcohol and illicit drug abuse continues to be a significant problem in the United States. 
Although access to treatment remains a hurdle for many who struggle with addiction, the extent 
to which treatment (once available) is effective in promoting recovery and preventing relapse 
remains unclear. Thus, the present study examined the relationship between clinical risk factors 
for substance abuse and their effects on treatment outcomes. Data was obtained from the 
Comprehensive Addiction Treatment Outcome Registry (CATOR; N=13,051), which was 
designed to provide substance abuse treatment programs with uniform forms that cover intake 
information and discharge, as well as treatment outcomes for 12 months post-treatment. From 
the original CATOR sample, predictors of treatment outcomes (i.e., relapse) at follow-up were 
examined in a total of 10,405 participants with complete data. Results suggested several 
variables to be significant indicators of relapse, including needle use, age of first drink, using 
multiple substances, depression, multiple substance diagnoses, the Big 5 cocaine items (craving, 
failing to fulfill responsibilities, withdrawal symptoms, giving up pleasant activities to use 
substances, and inability to reduce or stop substance use), history of substance abuse and past 
psychiatric history, as well as all of the behavioral risk items (meeting conduct disorder criteria 
as an adolescent, being arrested within the past year, and being arrested for a DUI/DWI). 
Secondary multivariate analyses, specifically a series of logistic regressions, were used to 
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determine if demographic factors were significant in the context of the clinical risk items. 
Results suggested that age, race, employment status and marital status remained significant and 
these variables were included as control variables. Third, it was determined that the significant 
clinical risk variables listed above, as well as the four demographic control variables, would be 
used to construct a global assessment tool measuring clinical risk factors of relapse for the 
purpose of identifying high risk clients.
  
 
 
 
INTRODUCTION 
 Currently, the area of examining clinical risk factors for substance use is a diverse avenue 
of study. Randomized clinical trials, one of the most common ways to evaluate evidence-based 
treatments, do not address which patients benefit the most from treatment. Since the DSM-5 
criteria lists different levels of severity for Substance Use Disorders, acknowledging that 
different levels of severity need different levels of intervention is important to acknowledge and 
deserves further study. In addition, often, experiments involving individuals in treatment often 
have small sample sizes, which significantly limits both statistical power and clinical inferences 
that can be drawn. The present study aimed to address some of these limitations, in part by 
utilizing data from the Comprehensive Addiction Treatment Outcome Registry (CATOR; 
N=13,051). With its large sample size, the CATOR dataset provides a unique opportunity for 
exploring the role of clinical risk factors in the prediction of relapse.   
 Nothing paints a clearer picture of the importance of investigating risk factors of relapse 
than the prevalence of substance use disorders (SUDs) in the United States. Alcohol and illicit 
drug abuse has been found to be quite prevalent in the US adult population, with lifetime rates of 
12 percent for alcohol abuse and 2 to 3 percent for abuse of illicit drugs (Merikangas & McClair, 
2012). In addition, according to recent surveys of private and publicly funded substance 
treatment centers, 22.7 million individuals age 12 or older have sought treatment for substance 
abuse problems, and only 2.5 million of those seeking services received treatment specifically 
for substance abuse (Substance Abuse and Mental Health Services Administration; SAMHSA, 
2014), irrespective of the type of substance that is being abused1.  
                                                          
1 The DSM-5 combined the previous two mutually exclusive categories of substance abuse and substance 
dependence into a new category called Substance Use Disorders (SUD; American Psychiatric Association, 2013). 
Research prior to the DSM-5 will refer to abuse or dependence as separate diagnoses and the literature review for 
this thesis will therefore reflect the language of the original studies. As such, substance abuse is viewed as a less 
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While there is a plethora of studies comparing SUD treatment outcomes for different 
treatment models, there is little on what clinical or other characteristics are associated with 
positive outcomes or prognosis. Studies that do consider variables that influence post-treatment 
outcomes tend to focus only on a single facet. For example, diagnoses such as nicotine addiction 
and smoking cessation (Baker, Piper, Schlam, Cook, Smith, Loh, & Bolt, 2012; Killen, 
Fortmann, Kraemer, Varady, & Newman, 1992; Reid, Jiang, Fallon, Sonne, Rinaldi, Turrigiano, 
Arfken, Robinson, Rotrosen, & Nunes, 2012; Van Zundert, Ferguson, Shiffman, & Engels, 2012) 
are popular avenues of research, but have a very narrow focus. In fact, there is a dearth of 
findings that can be generalized to a broader population of substance abusers. In addition to the 
narrow focus on specific diagnoses, studies on factors that have an effect on substance use 
treatment outcomes are often limited to very narrow populations, such as substance users with 
other co-occurring diagnoses, rural community based women, American Indians/Alaska Natives, 
or hospitalized veterans (Cridland, Deane, Hsu, & Kelly, 2011; Patitz, Anderson, & Najavitz, 
2015; Raylu & Kaur, 2012; Spear, Crevecoeur-MacPhail, Denering, Dickerson, & Brecht, 2013; 
Vayalapalli, Fareed, Byrd-Sellers, Stout, Casarella, Drexler, 2013).  
Adverse consequences of drug and alcohol use have also been cursorily examined, but 
further research into the clinical utility of these instruments as predictors of treatment outcomes 
is needed (e.g., Kazdin, 2006; Kiluk, Dreifuss, Weiss, Morgenstern, & Carroll, 2013; Tonigan & 
Miller, 2002). Furthermore, there is a noticeable gap in the literature on areas related to clinical 
and other risk factors that influence substance abuse diagnosis and severity as well as treatment 
outcomes. Finally, there is little agreement among researchers as far as key factors that affect 
                                                          
severe form of SUD compared to substance dependence. Moreover, the term addiction, which is used commonly in 
the substance use literature, refers to the loss of control that is inherent in the SUDs. Finally, substance misuse 
implies use that is typically consistent with an SUD, but where a formal diagnosis may not have been rendered.    
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treatment outcomes and relapse (Belin, Belin-Rauscent, Murray, and Everitt, 2013; Kilpatrick, 
Acierno, Saunders, Resnick, Best, & Schnurr, 2000; Tiffany, Friedman, Greenfield, Hasin & 
Jackson, 2011) and the validity of the current diagnostic criteria in the DSM for substance abuse 
diagnoses is widely debated (Martin, Chung, & Langenbucher, 2008; Kopak, Proctor, & 
Hoffmann, 2012, 2014; Kopak, Metze, & Hoffmann, 2014). The present study aimeds to add to 
the body of research by examining clinical risk factors as predictors of treatment outcomes (e.g., 
relapse vs. abstinence) in a large sample of individuals who completed substance abuse 
treatment. Findings may further assist in the development of a risk assessment tool, and may 
generalize to the broader population of individuals who abuse substances.  
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CHAPTER ONE: SUBSTANCE USE DISORDERS: PREVALENCE AND DESCRIPTION 
Substance Use Disorder (SUD), which involves impaired control, social impairment, 
risky use, and pharmacological criteria (DSM-5; American Psychiatric Association, 2013) is one 
of the most common psychiatric problems in the United States, with a 12-month prevalence rate 
around 15 percent (i.e., alcohol and illicit drugs; Merikangas & McClair, 2012). Individuals with 
an SUD (i.e., mild, moderate, or severe SUD; DSM-5; APA, 2013) engage in recurrent use of 
alcohol and/or drugs that causes clinically and functionally significant impairment, such as 
health problems, disability, and failure to meet major responsibilities at work, school, or home.  
Despite its prevalence, only a small fraction of individuals with an SUD receive treatment 
(National Institute on Drug Abuse, 2011) and there is little consensus as to which treatments are 
most effective in promoting positive outcomes (e.g., recovery, abstinence) and prevent relapse 
(e.g., Belin, Belin-Rauscent, Murray, and Everitt, 2013; Kilpatrick, Acierno, Saunders, Resnick, 
Best, & Schnurr, 2000; Tiffany, Friedman, Greenfield, Hasin & Jackson, 2011). Additionally, 
research on variables that predict treatment outcomes for SUD has yielded mixed findings, with 
no clear consensus on which clinical variables pose the greatest risk of poor outcomes. Given the 
prevalence of SUD, the barriers to treatment, and the inconsistent findings regarding treatment 
outcomes among those who do need and seek treatment, the present study addressed the 
aforementioned limitations in an effort to increase our understanding of SUD treatment 
outcomes, with a focus on select clinical variables that can be used in the assessment of risk in 
this population.     
Substance Use and Treatment Seeking 
According to SAMHSA’s National Survey on Drug Use and Health, 23.5 million 
individuals who are 12-years of age or older met the criteria for needing treatment for an illicit 
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drug or alcohol abuse problem in 2009. Of these, only 2.6 million, totaling 11.2 percent of those 
who needed treatment, received it at a facility specifically focused on the treatment of substance 
abuse problems (NIDA, 2011). In addition, there were 1.8 million admissions in 2008 for 
treatment of alcohol and drug abuse to facilities that report to State administrative data systems. 
The largest proportion of admissions, 41.4 percent, involved alcohol abuse. Heroin and other 
opiates accounted for the largest percentage of drug-related admissions at 20 percent, followed 
by marijuana at 17 percent. Publicly funded substance abuse treatment programs had similar 
statistics, with alcohol being the largest source of admissions, with the slight difference of 
marijuana admissions surpassing any other drugs (NIDA, 2011). These statistics show that not 
only are high proportions of the population in need of treatment for substance related issues, but 
that a significant number of those seeking treatment do not find the resources needed to 
effectively address their problems. Further, these data indicate the importance of examining risk 
factors for SUD severity (so as to identify those in most dire need of treatment), as well as the 
need to identify variables that contribute to outcomes among those who do access treatment. 
SUD Risk Factors and Treatment Outcomes 
As noted, prior to the year 2000, there was a significant gap in research focused on 
specific predictors of outcome in substance use treatment. A few exceptions (Rounsaville, 
Tierney, Crits-Cristoph, Weissman, & Kleber, 1982) focused on predictor variables that affected 
treatment outcomes, such as program retention, psychological symptoms, illicit drug use, illegal 
activities, and occupational functioning. However, the past fifteen years have seen an increase in 
the number of studies aimed at identifying risk factors for substance use, misuse (formerly abuse 
and dependence), and SUD treatment outcomes (e.g., Belin, Belin-Rauscent, Murray, and 
Everitt, 2013; Kilpatrick, Acierno, Saunders, Resnick, Best, & Schnurr, 2000; Laffey, McKellar, 
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Ilgen, & Moos, 2008; Tiffany, Friedman, Greenfield, Hasin & Jackson, 2011). For example, 
Laffey et al. (2008) found that having more severe substance use, more psychiatric symptoms, 
having more arrests prior to treatment, and belief in AA-style philosophy predicted substance use 
problem improvement four years post-treatment. Although several psychosocial variables 
(involvement with the criminal justice system, severity of psychiatric problems) play a role in 
treatment outcomes for substance use, clinical risk factors or specific symptoms of SUD have 
garnered recent attention.  
SUD Risk Factors and Craving 
One such risk factor worth examining is craving, which was added to the DSM-5 criteria 
for SUD (APA, 2013). Tiffany, Friedman, Greenfield, Hasin and Jackson (2011) and Belin, 
Belin-Rauscent, Murray, and Everitt (2013) examined craving as a factor in the diagnosis and/or 
treatment of substance abuse, and both found results that supported their claims. Moreover, Belin 
et al. (2013) added to the motivation-focused models of addiction, which posit that craving for 
substances is overwhelming and the person “has to take drugs”. In brief, Belin and colleagues 
pointed out that these models do not take into account adaptations such as ‘incentive 
sensitization’, where the individual will develop a strong desire (craving) due to the brain 
becoming hypersensitized to an addictive substance. Initially, this increases pleasure, which 
further increases craving (Robinson & Berridge, 2008). Both of these theories have merit, but 
more importantly, these theories both consider craving to be a significant area of study that 
should be included when examining risk factors of substance use and treatment outcomes.  
Along the same lines, Tiffany, Friedman, Greenfield, Hasin and Jackson (2011) evaluated 
currently accepted treatments for SUDs and the degree to which craving, self-efficacy, 
psychosocial functioning, quality of life, and social network/social support have an effect on 
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treatment outcomes. Examination of a multitude of variables suggested that the factors of 
change, self-efficacy, craving, psychosocial functioning, quality of life, and social network/social 
support met the guidelines for inclusion as predictors in future research and were recommended 
in treatment studies.  
As noted, most contemporary conceptualizations of drug disorders acknowledge that 
craving plays a central role in addictive processes, serving as both a cause and consequence of 
chronic drug use (Tiffany et al., 2011). Clinically, craving has substantial diagnostic and 
predictive relevance, and has been incorporated into DSM-5 as a defining feature of addiction. In 
sum, the domain of craving meets all the guidelines outlined above and should be included 
routinely as an outcome in studies of treatments for substance abuse (Tiffany et al., 2011). 
Collectively, these findings (e.g., Belin et al., 2013; Kopak et al., 2012, 2014; Tiffany et al., 
2011) suggest that although craving and other risk factors differ in their relative contribution to 
substance abuse and relapse, these variables should be the subject of future research. The 
CATOR has several items related to craving (i.e., preoccupation with getting high, scheduling 
their day around obtaining and/or using substances, desire for and/or inability to stop using), 
which were included in the present study.  
Evaluation of SUD Diagnostic Criteria 
Despite the clear importance of clinical indicators in the assessment and prognosis of 
SUDs, researchers and clinicians have not been able to reach a consensus regarding the current 
diagnostic criteria and if/how it should be revised (Kopak, Proctor, & Hoffmann, 2012, 2014; 
Kopak, Metze, & Hoffmann, 2014; Martin, Chung, & Langenbucher, 2008). Kopak and 
colleagues (2014) focused on the argument that five of the eleven DSM-5 criteria for SUDs have 
been found previously to be more strongly associated with a severe diagnosis and that these 
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criteria could be involved in an overarching loss of control that negatively impacts a person’s 
treatment outcome. This belief in an overarching loss of control is similar to the research of 
others mentioned previously (e.g., Belin et al., 2013; Tiffany et al., 2011), emphasizing craving 
as a risk factor which significantly impacts diagnosis and treatment outcomes. 
In order to test the validity of the current DSM diagnostic criteria, as well as bolster the 
argument that some criteria should be considered more important than others, Kopak, Proctor, 
and Hoffmann specifically examined the substance disorders criterion change from the DSM-IV.  
They did this by comparing the old criteria to the initial two DSM-5 diagnoses for cannabis use 
disorders (2012) and later published a related article discussing the implication of changes from 
the DSM-IV to the DSM-5 (2014), with the options of mild, moderate or severe SUD. Both of 
these articles focused on analysis of the idea that certain diagnostic criteria are more clinically 
significant than others and that those criteria need further research to prove their efficacy in 
substance abuse treatment. The specific criteria they evaluated, coined “The Big Five” by Dr. 
Hoffmann, were: experiencing withdrawal symptoms, desire and/or inability to stop or reduce 
use, no longer participating in recreational or other activities due to substance use, failing to 
fulfill obligations at home, school, or work, and craving or strong urge to use a substance. 
Using the criteria mentioned above, Kopak and colleagues suggested that some of the 
criteria measured were “cardinal indicators” of Severe Cannabis Use Disorder. This was based 
on the finding that certain criteria were present almost exclusively when the individual was 
classified in that diagnostic designation. Items representing the criteria of withdrawal symptoms, 
sacrificing activities in order to use, and craving substance use were almost exclusively endorsed 
by those inmates with SCUD for cannabis, with similar findings reported for alcohol. Kopak, 
Metze, and Hoffmann (2014) expanded upon the cannabis findings by studying an incarcerated 
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population to not only examine the DSM-IV compatibility of the recent changes in the DSM-5 in 
the area of alcohol use disorders, but also to test the hypothesis that certain diagnostic criteria 
could be used as indicators of a severe alcohol use disorder. Their results supported the 
hypothesis that not all diagnostic criteria were created equal and that some could be cardinal 
indications of more serious alcohol-related behavioral problems compared with others (Kopak et 
al., 2012, 2014). These findings are significant as they lend credence to the hypothesis that the 
presence of specific factors such as craving could be more significant than the presence of other 
factors, and further research should examine craving and other significant factors as predictors of 
outcomes2.  
Genetic Factors and Family History 
In addition to craving and other subjective psycho-emotional constructs, the recent 
decade has seen a search in the identification of quantifiable biological components of addiction. 
Although beyond the scope of the proposed study, research focusing on genetic and 
physiological components of substance abuse (Erblich, Bovbjerg, & Diaz, 2012; Hutchison, 
LaChance, Niaura, Bryan, & Smolen, 2002) has come to conclusions similar to Tiffany et al. 
(2011) and Kopak et al (2012; 2014) in the area of the significance of craving. For example, 
Hutchison et al. (2002) found that participants who were homozygous or heterozygous for the 
DRD4 VNTR allele, which has been linked to cue-elicited craving for tobacco, demonstrated 
significantly greater craving, more arousal, less positive affect and paid more attention to 
smoking cues than participants who were not homo- or heterozygous for the DRD4 VNTR allele 
(Hutchison et al., 2002). This lends evidence to the hypothesis that genetic factors (via craving, 
                                                          
2 The DSM-5 criteria will be used for the purpose of this study, and information from the CATOR database 
will be used that reflects this diagnostic criteria as closely as possible. 
  
 
10 
 
arousal, affect, and attention to cues) contribute to substance use, and may contribute also to risk 
for relapse.  
In addition, Erblich and colleagues’ study tested the hypothesis that cue and stress 
induced smoking had the same genetic predictors. Contrary to past research, findings indicated 
that variants in the glycine and dopamine pathways correlated with cue-induced craving, while 
variants in the stress-corticotrophin pathways were more strongly correlated with stress-inducing 
craving (Erblich et al., 2012). While the CATOR database does not include genetic factors 
specifically, it does contain questions regarding a family history of substance abuse, which could 
show a proximal link to the risk factors described above. 
Demographic Variables and Substance Use 
 In addition to the investigation of genetic factors and family history, demographic 
variables such as age and gender are commonly researched areas in substance use treatment. 
There is a significant body of research supporting the claim that older clients (ranging from 35-
55, depending on the study) have a higher probability of positive treatment outcomes (Oslin, 
Pettinatti, & Volpicelli, 2002; Satre, Mertens, Arean, & Weisner, 2004; Simpson, Joe, & Rowan-
Szal, 1997) than younger clients. Positive treatment outcomes include longer program retention, 
a higher percentage of abstinence from substances, and greater adherence to treatment.  
Gender differences are also important to mention, as research has shown that men 
reported more drug use and criminal involvement than women of similar age entering treatment 
at the same point (Hser, Huang, Teruya, & Anglin, 2003). Other psychiatric disorders have also 
been shown to affect substance use treatment outcomes differently across genders, as women 
with phobias have been shown to have better treatment outcomes than other disorders such as 
major depression, personality disorders, and generalized anxiety. Also, men with psychiatric 
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disorders in general had worse treatment outcomes, most specifically men with major depression 
and antisocial personality disorder (Compton, Cottler, Jacobs, Ben-Abdallah, & Spitznagel, 
2003).  
 For the purpose of this study – which focuses on clinical predictors of SUD treatment 
outcomes – some of the demographic and descriptive variables, such as gender, have been 
excluded. In contrast, given that previous research (e.g., Merline, O’Malley, Schulenberg, 
Bachman, Johnston, 2003) and preliminary examination of the CATOR data suggested that age, 
race, marital status, and employment status may have a significant effect on relapse and may 
influence also the clinical risk factors of interest to this study, these demographic variables have 
been retained as control variables in subsequent analyses of treatment outcomes.  
Needle Use and Risk for Relapse.  
Another variable that has been found to influence relapse following treatment is the use 
of needles to inject drugs intravenously. Most of the literature surrounding intravenous drug use 
focuses on reducing the risk of contracting common “needle diseases” such as hepatitis and 
HIV/AIDS, which occurs when intravenous drug users (IDUs) share infected needles. These 
included factors such as perceived risk and willingness to receive treatment among IDUs (Stein, 
Maksad, & Clarke, 2001), reducing the risk of contracting HIV/AIDs using treatments such as 
methadone (Ball, Lange, Myers, & Friedman, 1988) and the effectiveness of commonly used 
risk-reduction interventions for IDUs (Booth & Watters, 1994). However, one study (Shah et al., 
2006) examined the longitudinal predictors of needle use cessation and relapse for IDUs from 
1988 to 2000, following subjects from initial cessation to potential relapse. By the time the study 
concluded, three fourths of their 1327 subject sample had relapsed and begun using needles 
again, with the median time to relapse being 1 year. Shah and colleagues found several variables 
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associated with shorter time to injection relapse, such as being male, homelessness, HIV 
seropositivity, use of alcohol, cigarettes, non-injection cocaine, and having a longer time to the 
first cessation (Shah et al., 2005). Since needle use (to inject drugs) clearly has an effect on the 
possibility of relapse, it was included in the current study.  
SUDs and Drug Use Consequences  
When examining treatment outcomes and risk of relapse among individual with SUDs, a 
majority of the research has focused on changes in symptoms. However, symptom reduction 
(e.g., decrease in craving) and promotion of factors associated with abstinence (increase in 
coping) may not be sufficient in preventing relapse. In fact, adverse consequences of substance 
abuse (i.e., physical problems such as hangovers, feelings of guilt, and problems in interpersonal 
relationships) may also be important. In a meta-analysis of the Inventory of Drug Use 
Consequences (InDUC), Tonigan and Miller (2002) found that reductions in the frequency of 
drug use among polysubstance users did not consistently produce reductions in consequences of 
use. Specifically, Tonigan and Miller (2002) observed a 40 percent decline in frequency of 
substance use and a 33 percent decline in drug-related consequences. These findings suggest that 
changes in substance use consequences should be assessed separately from mere frequency of 
use, and that treatment may focus on both areas as possible avenues for intervention.  
Similarly, Kiluk, Dreifuss, Weiss, Morgenstern, and Carroll (2013) evaluated the 
reliability and validity of the Short Inventory of Problems – Revised (SIP-R) across a large 
sample of individuals with substance use disorders. Findings suggested that the SIP-R measured 
an overall construct of substance use consequences independent of frequency of use. The results 
also supported the internal reliability and convergent validity of this tool for measuring 
consequences of drug and alcohol use. Most important, higher SIP-R scores were strongly 
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associated with poorer treatment retention even after controlling for baseline substance use, 
Addiction Severity Index composite scores, and readiness to change. At the time, this was the 
first study to demonstrate the SIP’s ability to predict treatment retention, which strengthened the 
utility of the SIP-R as a baseline assessment tool in treatment-seeking populations.   
Overall, these studies provide evidence that consequences of drug and alcohol use can 
reliably be measured and are important factors to consider when discussing treatment outcomes.3  
SUDs and Arrest  
In addition to the many physical-, interpersonal-, and intrapersonal problems, and the 
high rate of relapse, substance use problems are associated also with a risk for involvement with 
the criminal justice system (i.e., e.g., arrests, incarceration; Asberg & Renk, 2013; Beck, 
Harrison, & Karberg, 2002). According to 2012 statistics from the Department of Justice’s 
Bureau of Justice Statistics, the total correctional population was estimated to be 6,937,600, with 
4,794,000 individuals on probation or under parole supervision, and drug law violations 
accounting for the most common type of criminal offense (Glaze & Herberman, 2013). In a 
survey of State and Federal prisoners, the BJS estimated that about half of the prisoners met 
DSM-IV criteria for drug abuse or dependence, and yet fewer than 20 percent who needed 
treatment received it (Chandler, Fletcher, & Volkow, 2009; Karberg & Mumola, 2006). 
Specifically, of those surveyed, 14.8 percent of State and 17.4 percent of Federal prisoners 
reported having received drug treatment since admission (Karberg & Mumola, 2006). 
                                                          
3 Findings are also of relevance to the current study in that one of the aims is to create an additive scale. 
Such a scale would include questions similar to those on the InDUC and the SIP-R. A short scale focused on very 
specific risk factors with an easy scoring template would allow clinicians to administer the instrument and have 
results quickly, as well as be able to identify those clients with risk factors that will need to be addressed in 
treatment. 
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Overall, although the past several decades have seen an increased interest in providing 
substance abuse treatment services for criminal justice offenders and reducing recidivism, only a 
small percentage of offenders has access to adequate services, especially in smaller jails and 
correctional facilities (Sabol, West, & Cooper, 2010; Taxman, Perdoni, & Harrison, 2007). Not 
only is there a gap in the availability of these services for offenders, but often there are few 
choices in the types of services provided. Treatment that is of insufficient quality and intensity or 
that is not well suited to the needs of offenders may not yield meaningful reductions in drug use 
and recidivism (citation). Untreated substance abusing offenders are more likely than treated 
offenders to relapse to drug abuse and return to criminal behavior. This can lead to re-arrest and 
re-incarceration, jeopardizing public health and public safety and taxing criminal justice system 
resources (citation). Treatment is the most effective course for interrupting the drug 
abuse/criminal justice cycle for offenders with drug abuse problems. Given that the research 
shows an important and complex relationship between incarceration and substance use and the 
fact that the CATOR gives access to data such as incarceration within the past year as well as 
arrests related to substance use, these variables were included in the present study.  
Substance Abuse and Behavioral Risk Factors 
In addition to identifying risk factors related to relapse, researchers have also 
concentrated their efforts to determine the factors that can help predict long-term outcomes 
among individuals with substance use problems (Clingempeel, Henggeler, Pickrel, Brondino, & 
Randall, 2005; Squeglia, Jacobus, Nguyen-Louie, & Tapert, 2014). For example, Clingempeel 
and colleagues examined predictors of use in adults that had been treated for substance abuse as 
adolescents. Findings suggested that frequency of marijuana use and the number of comorbid 
psychiatric disorders diagnosed in adolescence predicted later cannabis use (Clingempeel et al., 
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2005). Moreover, Squeglia et al. (2014) utilized a longitudinal design and found that adolescents 
who were less inhibited prior to engaging in any form of substance abuse were more likely to 
engage in frequent and heavy alcohol and marijuana use by the time they reached late 
adolescence. Overall, specific characteristics in adolescence (i.e., illicit substance use, conduct 
problems, impulsivity) may be important risk factors to consider also among adults diagnosed 
with SUD given their association with more severe or chronic use. 4 
For example, a recent study by Lister, Ledgerwood, Lundahl, and Greenwald (2015) 
explored how cocaine use consequences affected the relationship between impulsiveness and 
depressive symptoms in a sample of cocaine users. Lister et al., (2015) found that impulsiveness 
subscales (attentional, non-planning, and motor) were all positively correlated with an earlier age 
of first use, a higher degree of current depression symptoms, and a greater number of 
consequences linked to lifetime cocaine use (Lister et al., 2015). These results suggest that 
further analysis of the relationship between traits such as impulsiveness and substance use is 
needed, as well as the role that substance use consequences can play on co-occurring disorders 
such as depression (Lister et al., 2015).  
  Moreover, the research by Lister et al. serves to bridge the gap between researchers 
studying particular traits or consequences in regard to treatment outcomes and those that are 
studying the effects of particular treatment approaches, particularly Cognitive Behavioral 
Therapy (CBT), on individuals with co-occurring disorders such as substance abuse and 
depression (e.g., Boger, Auerbach, Pechtel, Busch, Greenfield, & Pizzagalli, 2014; Hunter, 
                                                          
4 Since all of the subjects in the CATOR database are over the age of eighteen it could be difficult to 
examine this in the proposed study, but participants did answer questions that included the DSM-IV criteria for 
diagnosing a Conduct Disorder in adolescence. The presence of three or more of these criteria, which would 
constitute a diagnosis, was used in an attempt to examine adolescent behavioral risk factors and risk of relapse. 
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Witkiewitz, Watkins, Paddock, & Hepner, 2012; Lydecker, Tate, Cummins, McQuaid, 
Granholm, & Brown, 2010).  
  Boger et al. (2014) added a reward responsiveness task to the treatment of an adolescent 
inpatient sample to measure whether depressive symptoms and motivation for change were 
improved over the course of treatment using the two therapeutic approaches of CBT and 
Dialectical Behavioral Therapy. Findings supported the hypothesis that adolescents demonstrated 
significant reductions in depressive symptoms and improved motivation for change in relation to 
drug use over the course of acute residential treatment, as well as improved reward 
responsiveness from admission to discharge. These results show promise for the future of 
treating comorbid depression and substance abuse, particularly in adolescents as it suggests that 
addressing reward responsiveness would improve treatment outcomes in this population (Boger 
et al., 2014). 
 In a similar vein, Hunter et al. (2012) and Lydecker et al. (2010) both used adult 
populations and CBT to study the effectiveness of treatments targeting co-occurring depression 
and substance abuse. Both found that both variations of Cognitive-Behavioral Therapy (CBT), 
when compared to either standard inpatient substance abuse treatment or a traditional Twelve 
Step Facilitation therapy (TSF), were linked to more stable symptom reduction for both 
depression and substance use. Both of these studies suggest that the longitudinal relationship 
between depression and substance abuse disorders is important, and that both can be improved 
using evidence-based treatment such as CBT.  
In addition to depression, eating disorders and past physical abuse have been found to 
commonly co-occur with substance use (Liebschutz, Savetsky, Saitz, Horton, Lloyd-Travaglini, 
& Samet, 2002 ; Puhl, Cason, Wojnicki, Corwin, & Gripson, 2011). For example, Liebschutz et 
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al. found that a history of physical and/or sexual abuse was highly associated with substance use 
and substance use consequences measured on the InDUC, while Puhl et al.’s findings suggested 
a link between binge eating and addiction to other substances such as cocaine. These findings 
may point to underlying problems with impulse control or disinhibition, or with disturbances is 
self-regulation (Liebschutz et al., 2002; Puhl et al., 2011). Although clients with co-occurring 
disorders may be more difficult to treat (Hunter et al., 2010; Lydecker et al., 2012) and face also 
poorer outcomes following treatment (Boger et al., 2014; Hunter et al., 2010; Lydecker et al., 
2012), current research clearly emphasizes the importance of treating the SUD and any co-
morbid clinical issue. Collectively, studies suggest that evidence-based treatment approaches can 
be effective and have the potential to improve treatment outcomes, but more research is needed. 
Thus, identifying disorders that commonly occur with SUDs is an important component of the 
proposed study, as it may not only aid in getting clients the focused or individualized treatment 
that they need, but may help also to improve long-term treatment outcomes such as the potential 
for relapse. The CATOR database gives access to information about past psychiatric history, as 
well as detailed questions related to depression and past substance use treatment.  
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CHAPTER TWO: PRESENT STUDY 
Based on previous research, there is evidence suggesting that factors such as family 
history of substance abuse, use of multiple substances, severity of alcohol consumption, age of 
beginning substance use, and arrests, have effects on substance abuse treatment outcomes. In 
addition, the role of craving has garnered significant attention in recent years, and is now 
included in the DSM-5 as a criteria for SUD. This research highlights the importance of 
examining the link between clinical risk factors and treatment outcomes for individuals with 
SUD (Aguiar et al., 2012; Hien et al, 2010; Madoz-Gurpide et al., 2004; McClellan et al., 1983, 
Simpson, Joe, & Broome, 2002). Most of the existing research, however, only mentions risk 
factors in the context of comparing treatment models, and, to our knowledge, none of the studies 
have prognostic indicators as the main reason for the study. The present study aimed to 
specifically identify prognostic factors of relapse, not in the context of any treatment models.  
Given the prevalence of substance use in the United States (NIDA, 2011), combined with 
the lack of research focused solely on prognostic factors related to relapse following treatment, 
the present study examined the relationship between selected clinical risk factors and the 
association with the negative treatment outcome of relapse. The focus was on identifying 
prognostic indicators of relapse as identified by the body of research and availability of 
information in the CATOR database.  Additionally, the present study will examine the complex 
relationship between substance use disorders and commonly co-occurring disorders such as 
depression, eating disorders, and past abuse, as well as the relationship between behavioral risk 
factors (e.g., meeting the criteria for a conduct disorder as an adolescent, an arrest in the past 
year, and an arrest for a DUI) and substance use disorders, and how these factors can contribute 
to relapse.  
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Research Questions 
This study sought to answer the following questions: Which, if any, of the Big Five risk 
factors for alcohol, cannabis and cocaine use predict relapse? What, if any, clinical severity 
items for substance abuse predict relapse? What, if any, historical risk items for substance use 
predict relapse? Are there significant relationships between the commonly co-occurring 
disorders selected and relapse? Are there relationships between the three behavioral risk items 
and relapse?  
Hypotheses 
Several preliminary hypotheses were identified pre-analysis. It is believed that the Big 
Five risk factors for alcohol, cannabis and cocaine use as measured by the CATOR will be 
significant predictors to severity of SUD as the number of symptoms positively endorsed by a 
participant increase.  Significant relationships predicted to exist for all of the clinical severity 
items (needle use, age of first drink, Big 5 alcohol, cannabis, and cocaine, time since last 
substance use, and number of substances used in the past week). Dependencies are predicted to 
exist for all four of the historical risk items (history of physical abuse, history of seeking 
psychiatric services, history of depression, and/or history of eating disorders) identified on the 
Comorbid Disorders scale. All three of the behavioral risk items (conduct disorder, number of 
arrests one year prior to treatment, DUI/DWI arrests) should be significantly related to relapse. 
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CHAPTER THREE: METHODS 
Participants 
 Of the included 13,051 subjects in the database, 2,646 were excluded for a variety of 
reasons, such as not completing the CATOR forms, falling outside the 18 to 65 age range, non-
completion of treatment, or non-completion of 12-months of follow-up.  This left a sample of 
10,405 subjects for analysis. Thus, the sample for the study is comprised of 10,405 individuals 
who completed substance use treatment, as well as 12 months of post-treatment follow up. The 
sample was predominantly male 7,505 (72%) with 2,900 (28%) females. The sample included 
only those individuals between the ages of 18 and 65 years, making it a purely adult sample. The 
median age of subjects who did not relapse within a year of completing treatment was 37.15 
years old and a standard deviation of 10.76 years, while the median age of subjects who relapsed 
within a year of completing treatment was 34.14 years old, with a standard deviation of 10.39 
years. The majority of the participants were Caucasian, forming 8,966 (87%) of the sample, with 
a combination of Asian, Native American, African American, Biracial, Hispanic and ‘Other’ 
comprising the remaining 1,288 (13%) subjects.    
Data 
This quantitative study used archival data. Data collection ended in 1995, so the data set is dated 
from a psychological standpoint, but it is useful as it reflects results from a time when substance 
abuse treatment was more driven by clinical significance than economics. The data was stripped 
of all personal identifiers and imported into SPSS for analysis. In addition to SPSS, Stata 11 
statistical software (StataCorp, 2009) was used to code and analyze the data (N=10,405). 
Collection and use of the data was approved by the IRB through the Education Research 
Foundation and Ramsey Clinic Associates.  
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Materials and Procedures 
 All participants filled out the fourth version of the Comprehensive Addiction Treatment 
Outcome Registry (CATOR), which was designed to provide substance abuse treatment 
programs with uniform forms that cover intake information and discharge, as well as treatment 
outcomes for 12 months post-treatment. This registry was headquartered out of Minnesota and 
was the largest commercial outcome monitoring service at the time of data collection, which as 
stated above ended in 1995. The CATOR forms consisted of eight pages that attempted to gather 
an extensive history on all subjects entering inpatient or outpatient treatment programs. These 
included questions regarding demographic factors such as race, age, gender, education level, etc. 
as well as past psychiatric diagnoses and treatment history, if any. A comprehensive history of 
substance use and family history of substance use was also included in the CATOR forms. Based 
on the hypotheses (see page 20) and available information retrieved from the archival data, four 
sets of variables were created to encompass clinical and behavioral risk factors, as well as factors 
related to co-occurring disorders to explore substance use disorder indicators.  
Variable Set 1: Addiction Severity 
The first set, named Addiction Severity Items, included constructs identified by previous 
research (Dutra, Stathopoulou, Basden, Leyro, Powers, & Otto, 2008; Kopak et al, 2012, 2014; 
Shah et al, 2006) as measuring the scope and severity of addictions. These items were needle 
use, time since last use, number of substances used in the past week, age of first drink, Big 5 
indicators of alcohol use disorder, Big 5 indicators of cannabis use disorder, and Big 5 indicators 
of cocaine use disorder. All of the items chosen to be measured were then coded into Stata 11. 
For time since last use the item was coded with a 0 or 1, measuring the longest period of sobriety 
in the past year. Subjects received a 1 if they had gone more than a month in the past year 
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without using substances, 0 is anyone who had not gone more than one month without using 
alcohol or drugs in the past year. All three of the Big 5 indicators of substance use disorders were 
sum scales ranging from zero to six, and if anyone endorsed the items listed in the Big 5, they 
received a one for each item independently. These were then tallied up, and the final score 
became the Big 5 score for alcohol, cocaine, or cannabis. The first item included in the Big 5 
measures was a desire to cut down on substance use, second was being consistently preoccupied 
with drinking or getting high, the third item was missing work or school because of drinking or 
drug use, fourth was neglecting responsibilities because of drinking or drug use, and the fifth 
item was having drank or used drugs to relieve a hangover. Anyone with a score of zero did not 
endorse any of those items, and anyone who said yes to any of the five received a one for each 
item they endorsed. Needle use was coded with a zero or one, where people who had used 
needles to inject drugs got a one, people who had never used drugs intravenously were coded as 
a zero. Age of first drink simply reported the age of the subject at first drink, ranging from 9-50 
years. Ultimately, the purpose was to analyze if age of first drink predicted relapse, with the 
hypothesis that the younger the age of initiation of drinking, the higher the probability of relapse. 
Number of substances used in the past week measured how many substances subjects used daily 
in the year prior to entering treatment. It ranged from zero to five, with zero meaning the subject 
had used no substances daily in the year prior to treatment all the way up to five, meaning the 
subject had used five substances daily in the year prior to treatment.  
Variable Set 2: Co-Occurring Disorders 
The second set of indicators of treatment outcome, named Co-Occurring Disorders, 
included assessments of depression or an eating disorder in conjunction with substance abuse 
diagnoses. Number of diagnoses measured specifically substance use diagnoses. It ranged from 
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1-6, as anyone in treatment had at least one substance use disorder diagnosis for alcohol, 
marijuana, cocaine, stimulants, opiates, and other drugs (includes sedatives, tranquilizers, and 
painkillers).  Participants were coded with a six if they had met criteria for six substance use 
disorder diagnoses. Depression was coded with zero and one, with one representative of a time 
lasting at least two weeks that the subject felt depressed or did not care about or enjoy anything. 
Eating disorder was framed similarly to depression, asking if there was ever a time that lasted at 
least three months when the subject binged on large quantities of food at least twice a week and 
then vomited or used laxatives to counteract the effects of the binge. Additionally, it asked if 
there was ever a time where they thought themselves overweight even though others said they 
were already thin. If they said yes to either or both, they received a one for the presence of an 
eating disorder, and were scored a zero if they answered no to both questions.   
Variable Set 3: Behavioral Risk.  
The third set of indicators of treatment outcome, Behavioral Risk Factors, included 
measures of behavioral and/or antisocial issues as indicated by arrests, behavioral risk factors as 
indicated by meeting the criteria for a conduct disorder diagnosis, and arrest for a DUI. It is 
important to include impulsivity and arrests within the past year on the same scale due to the 
possibility of a continuum of impulsivity to antisocial behavior. An arrest as an adult was 
considered to be consistent with Antisocial Personality Disorder. Since not all adolescents with 
conduct disorder indications go on to become antisocial, giving a point independently for 
adolescent conduct disorder symptoms and arrests gives the most weight for those who meet 
both. The conduct disorder scale had 8 items that responders were told to answer about 
themselves before the age of 15. These items included whether  participants had  ever skipped 
school more than 10 times, been suspended or expelled from school, gotten arrested, run away 
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from home overnight more than once, vandalized or destroyed property, shoplifted or stolen, had 
sexual intercourse with more than one person, or started physical fights. This Conduct Disorder 
measure was recorded as zero if there was the presence of only 2 or less conduct disorder 
indicators and one, if participants endorsed 3 or more conduct disorder indicators, which would 
meet the diagnostic criteria for a conduct disorder. Arrests a year prior to entering treatment 
measured how many times the participant had been arrested for 10 types of offenses in the year 
prior to entering treatment, including speeding/moving violations, disorderly conduct, 
assault/battery, theft/robbery/burglary, prostitution, vandalism/destruction of property, 
possession of drugs/paraphernalia, selling drugs, other. Number of arrests ranged from 0-20. The 
hypothesis was that the more times a subject was arrested, the more likely they were to relapse. 
An item was designed specifically to measure whether subjects had ever been arrested for a 
DWI/DUI, with a zero meaning no DUI/DWI, and a one meaning they had at least one 
DUI/DWI.  
 Variable Set 4: Historical Risk 
The fourth set of indicators of treatment outcome, Historical Risk Items, included a 
family history of substance abuse, the subject’s past psychiatric history, as well as a history of 
physical abuse. Physical abuse measured if participants had ever been hit or beaten so hard that it 
had left marks or it injured the person who hurt them, with a yes to either question receiving a 
one and no to both a zero. Family history of substance abuse asked whether drinking or drug use 
by a family member had repeatedly caused family health or legal problems, with a yes scored as 
a one and a no as a zero. Past psychiatric history asked if they had ever been treated by a 
psychiatrist or psychologist for any emotional disorder, with a yes scored as a one and no a zero. 
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As mentioned above, certain demographic factors (age, marital status, employment status, 
and race) were included in the analyses as control variables. The intent of this is to minimize the 
effect these variables have on the clinical items identified.  
Data Analysis Plan 
First, bivariate methods, specifically Chi-square tests and ANOVAs were conducted with 
Stata 11 software to determine if the constructs of the four sets of items were associated with the 
treatment outcome of relapse and to investigate associations between items. Specifically, Chi-
square tests were used for categorical variables. Chi-square tests determine whether the 
distribution observed in the data is significantly different than what could be expected due to 
chance. If evidence supports the presence of a significant bivariate association, further tests can 
be conducted to determine if these relationships remain while controlling for other factors.  Other 
variables, such as the number of weeks of longest sobriety, required the use of analysis of 
variance (ANOVA) due to the fact that they were measured at the interval or ratio level, and had 
two or more categories to compare. ANOVAs allow to test for differences among the means of 
two or more groups without conducting numerous t-tests and increasing the chances of making a 
Type I error. Additionally, ANOVAs measure the amount of variability both within and between 
groups, as well as how similar the groups are to each other.  
Lastly, multivariate methods, specifically a series of logistic regression model, were 
examined for each of the four sets of items. Logistic regression was the appropriate technique 
given that the outcome (relapse) is categorical, as well as giving the opportunity to determine the 
relative importance of certain predictors.  
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CHAPTER FOUR: RESULTS 
Descriptive Statistics  
 Participants were divided into two categories based on the dependent variable, whether 
they had relapsed in the 12 months after leaving treatment or whether they had remained 
abstinent (Table 1). Significant differences were found for age, race, employment status and 
marital status when it came to whether a client relapsed. The analysis showed that the group 
highest at risk for relapse was younger (M = 34.14, SD = 10.39, F (47, 10,357) = 5.82, p=.000), 
disproportionately non-white (χ² (1, N=10,405) = 23.4, p<.01), disproportionately unemployed 
(χ² (1, N=10,405) = 40.11, p<.01), and disproportionately never married (χ² (1, N=10,405) = 
102.82). There were no significant differences found across gender in relation to relapse. No 
differences in relapse outcomes by gender group (χ² (1, N=10,405) = 0.05, p<.01).  
Table 1. Descriptive statistics of 10,405 substance use treatment patients by 1 year post – treatment outcome 
 
 Relapse No Relapse 
Variable %/ M(SD) %/ M(SD) 
Age* 34.14(10.39) 37.15(10.76) 
Gender   
Female 41% 58% 
Male 41% 58% 
Race*   
Non-White 48% 52% 
White 41% 59% 
Employment status*   
Unemployed 47% 53% 
Employed 40% 60% 
Marital status*   
Never married 49% 51% 
Other 39% 61% 
Note. Differences between outcome groups were tested using chi-square tests for categorical variables and t-tests for 
continuous variables.  
*p < .001 
 
Clinical Risk Factors  
Logistic regression analysis found statistically significant factors in each of the four 
blocks. Table 2 shows that in the Addiction Severity Items scale, Big 5 Cocaine, needle use, and 
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number of weeks of longest sobriety were found to be significant χ²(1, N = 10,405) = 390.21, p 
=.000 , even when the selected demographic factors (age, race, employment status and marital 
status) were controlled for. For every additional year of age, participants experienced an average 
2% decrease (OR = 0.98, 95% C.I. = 0.97 – 0.98) in the odds of relapse.  
Table 2. Addiction Severity Items Logistic regression results predicting relapse within 1 year of discharge from 
treatment 
Variable Odds ratio Standard Error z P>|z| 
95% CI 
Lower Upper 
Age* 0.98 0.00 -8.12 0.000 0.97 0.98 
Race* 1.23 0.07  3.28 0.001 1.09 1.39 
Unemployed* 1.31 0.06  5.59 0.000 1.19 1.43 
Never married* 1.19 0.06  3.38 0.001 1.08 1.31 
Time since last use 1.07 0.04 1.68 0.092 0.99 1.17 
Big 5 Alcohol 1.01 0.01 0.51 0.614 0.98 1.03 
Big 5 Cannabis 0.98 0.01 -1.68 0.094 0.95 1.00 
Big 5 Cocaine* 1.05 0.01 3.67 0.000 1.02 1.08 
Needle use* 1.33 0.08 4.55 0.000 1.18 1.50 
Age of first drink  1.00 0.01 0.82 0.414 0.99 1.01 
Number of substances 
used in a week* 
1.14 0.02 6.62 0.000 1.10 1.19 
*p ≤ .001 
 
 Table 3 shows that a subject’s past psychiatric history as well as a history of physical 
abuse were found to be significant (having a past history of abuse increased the odds of relapse 
by 11% (OR = 1.11, 95% C.I. = 1.01-1.21) and being treated for an emotional disorder in the 
past increased the odds of relapse by 16% (OR = 1.16, 95% C.I. = 1.07-1.27)) when 
demographic factors were controlled for. Inconsistent with past research, a history of prior 
physical abuse or family history of substance abuse was not shown to be a significant contributor 
in post-treatment relapse. 
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Table 3. Historical Risk Items Logistic regression results predicting relapse within 1 year of discharge from  
treatment 
 
Variable Odds ratio Standard Error z P>|z| 
95% CI 
Lower Upper 
Age* 0.98 0.00 -10.56 0.000 0.97 0.98 
Race* 1.34 0.08 4.87 0.000 1.19 1.51 
Unemployed* 1.28 0.06 5.18 0.000 1.17 1.41 
Never married* 1.18 0.06 3.19 0.001 1.06 1.30 
Physical abuse* 1.11 0.05 2.22 0.027 1.01 1.21 
Family history of 
substance use 
0.93 0.04 -1.61 0.108 0.86 1.02 
Psychiatric history* 1.16 .0516793 3.44 0.001 1.07 1.27 
*p ≤ .001 
 
 Series of regression analysis of the Co-Occurring Disorders scale contained in Table 4 
shows that the subject’s number of psychiatric diagnoses was found to be significant, as well as 
meeting the criteria for a depression diagnosis. Having either several substance specific 
diagnoses (OR = 1.12, 95% C.I. = 1.06-1.18) or suffering from depression (OR = 1.12, 95% C.I. 
= 1.03-1.22) both increased the odds of relapse by 12% each.  
 
Table 4. Co-Occurring Disorders Logistic regression results predicting relapse within 1 year of discharge from 
treatment  
 
Variable Odds ratio 
Standard 
Error z P>|z| 
95% CI 
Lower Upper 
Age* 0.98 0.00 -8.99 0.000 0.97 0.98 
Race* 1.32 0.08 4.58 0.000 1.17 1.49 
Unemployed* 1.29 0.06 5.38 0.000 1.18 1.42 
Never married* 1.17 0.06 3.03 0.002 1.06 1.29 
Depression* 1.12 0.05 2.71 0.007 1.03 1.22 
Number of substance 
diagnoses* 
1.12 0.03 4.40 0.000 1.06 1.18 
Eating disorder  0.87 0.07 -1.67 0.094 0.75 1.02 
*p ≤ .001 
 
 Analysis of the Behavioral Risk Items shows that all three items (conduct disorder as an 
adolescent, an arrest 1 year prior to entering treatment, and a DUI arrest) were all found to be 
significant factors related to relapse. Surprisingly, a DUI/DWI arrest decreased the odds of 
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relapse (OR = 0.80, 95% C.I. = 0.71-0.90). Additionally, an arrest one year prior to entering 
treatment (OR = 1.07, 95% C.I. = 1.03-1.12) only increased the odds of relapse by 7 percent, 
which is also lower than might be expected. Conduct Disorder as an adolescent had the largest 
effect, increasing the odds of relapse by 26 percent (OR = 1.26, 95% C.I. = 1.15-1.39). These 
results, particularly the large effect that meeting the criteria for a Conduct Disorder as an 
adolescent had on relapse, lend credence to the hypothesis that impulsivity can have a significant 
effect on a person’s likelihood to relapse.  
 
Table 5. Behavioral Risk Items Logistic regression results predicting relapse within 1 year of discharge from 
treatment  
Variable Odds ratio 
Standard 
Error z P>|z| 
95% CI 
Lower Upper 
Age* 0.98 0.00 -8.93 0.000 0.98 0.98 
Race* 1.31 0.08 4.46 0.000 1.16 1.48 
Unemployed* 1.28 0.06 5.27 0.000 1.17 1.41 
Never married* 1.17 0.06 3.10 0.002 1.06 1.29 
Conduct disorder as an 
adolescent* 
1.26 0.06 4.95 0.000 1.15 1.39 
Arrested 1 year prior to 
entering treatment* 
1.07 0.02 3.40 0.001 1.03 1.12 
DUI/DWI arrest * 0.80 0.05 -3.79 0.000 0.71 0.90 
*p ≤ .001 
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CHAPTER FIVE: DISCUSSION 
Given the prevalence of substance use and misuse in the adult US population, the high 
risk of relapse among those who access treatment for problems associated with their use, and the 
staggering emotional, financial, and societal costs associated with SUDs, research that examines 
risk factors and aims to improve on current assessment of risk is of utmost importance. The main 
objective of the present study was to examine clinical risk factors previously identified in 
research and determine their utility as predictors of outcomes. Utilizing a large (>10,000 
participants) sample of treatment completers, this study presents also a unique opportunity to 
examine treatment outcomes independent of specific treatment models. Findings also allowed us 
to identify items for inclusion in a brief instrument to predict risk of relapse in this population.  
 As hypothesized, findings showed that certain clinical risk factors were more important 
than others in predicting negative treatment outcomes. Among variables included in the 
Addiction Severity Index, the Big 5 cocaine items, needle use, and the number of different 
substances a responder used daily in the year prior to treatment were all found to be significantly 
correlated with relapse. However, since cocaine use has been found to be less popular in recent 
years compared to newer drugs such as methamphetamines, measuring cocaine use specifically 
was not considered as important as measuring general substance use. For the purpose of 
designing the instrument, the five significant SUD diagnostic criteria (craving or strong urge to 
use substances, inability to stop/reduce use, failing to fulfill responsibilities at home, work, or 
school, experiencing withdrawal symptoms, not engaging in activities previously enjoyed, and 
preoccupation with getting/using substances) were included in reference to non-specific 
substance use.  
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 Next, findings suggested that two Historical Risk items were significant predictors of 
relapse: a history of experiencing physical abuse and being treated for an emotional disorder in 
the past. These items were retained for inclusion in the instrument. It is important to point out 
that programs such as Seeking Safety (Najavits, 2002), which are designed to treat trauma and 
substance use concurrently by teaching healthy coping skills, may be particularly helpful to 
substance using clients who endorse abuse and/or psychological symptoms stemming from 
trauma. In addition, maladaptive avoidance coping in the form of using substances has been 
shown to mediate fully the association between trauma symptoms and substance use 
consequences among female survivors of trauma (child sexual abuse; Asberg & Renk, 2012), 
suggesting the importance of assessing for a history of abuse, as well as for current ways of 
coping.  
 Moreover, in the set of items pertaining to Co-Occurring Disorders, meeting the criteria 
of a diagnosis of depression and the number of substance specific diagnoses were found to be 
significantly and positively correlated with relapse in this sample. For the substance specific 
diagnoses, the higher the number of diagnoses, the higher the risk of relapse. This is consistent 
with previous research on the link between psychiatric diagnoses and relapse. For the purposes 
of a truncated instrument, questions were shortened to ask clients if they had multiple substance 
specific diagnoses (rather than asking them to give a specific number of diagnoses) and whether 
or not they had ever been diagnosed or treated for depression. Meeting the criteria of an eating 
disorder did not predict relapse, and an explanation for that may be that since this was a 
primarily male sample and eating disorders are found to be more prevalent in females, a more 
female sample might prove to have different results.  
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 Next, all three of the items grouped into Behavioral Risk items were found to be 
significantly correlated with relapse. These items were: meeting the criteria for a Conduct 
Disorder as an adolescent, being arrested in the year prior to entering treatment, and being 
arrested for a DUI/DWI. Interestingly, being arrested for DUI/DWI decreased the risk of relapse. 
Although legal problems are no longer a criteria for SUD in the DSM-5, it is possible that such 
an arrest provides additional incentive in terms of abstaining from substance use. Moreover, the 
inclusion of these behavioral risk items in the truncated scale included some modifications. 
Specifically, since the general population cannot be assumed to be familiar with the diagnostic 
criteria of Conduct Disorders, the truncated instrument created in the study included questions 
outlining the criteria for a Conduct Disorder. Moreover, instead of specifically asking about the 
10 types of offenses outlined in the CATOR database, one question asked about general arrests, 
and a second question inquired about being arrested for a DUI/DWI. Despite the anomalous 
results of finding that an arrest for a DUI/DWI decreased the risk of relapse, it was still 
considered important to include in the instrument.  
Additional Clinical Implications 
Since this study focused primarily on identifying clinical risk factors that predict relapse, 
demographic factors did not receive a lot of attention. However, analysis showed that several 
demographic items could not be ignored. In line with previous research, participants’ age, race, 
employment and marital status were all shown to play important roles in the nature of risk factors 
for relapse, and thus were included as control variables. Even after being controlled for, they 
were almost universally predictive in all of the models, so clearly there is importance in these 
factors. For example, age has long been associated with substance use. Past research has linked 
the age of first substance use with several issues, such as more serious substance use problems in 
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adulthood, more negative treatment outcomes than those who started drinking later in life, and 
higher psychopathology (Hawkins, Graham, Maguin, Abbott, Hill, & Catalano, 1997; McGue, 
Iacono, Legrand, Malone, & Elkins, 2001; Musher-Eizenman, Holub, & Arnett, 2003). The 
findings of the study were consistent with the body of research.  
 Being a minority was a significant predictor for relapse despite making up only a small 
portion of the sample compared to Caucasians, which is a common outcome of studies 
examining issues such as substance use (Alegria, Canino, Ríos, Vera, Calderón, Rusch, & 
Ortega, 2014). More specifically, African Americans seem to be consistently over-represented 
when it comes to an increased risk of relapse (Cooper, Peirce, & Huselid, 1994). 
 Also, findings of the current study regarding employment and marital status are in line 
with those of McCaul, Svikis, and Moore (2001), who found that employment and being 
married, as well as being Caucasian and male, improved treatment retention, irrespective of the 
type of substance (i.e., alcohol, drugs, or combined substance use). A 2004 study found very 
similar results, with being unemployed and substance use in high school increasing the chances 
of substance use in adulthood, while being married decreased the likelihood of substance use 
(Merline, O’Malley, Schulenberg, Bachman, & Johnston, 2004).  In contrast to our findings and 
those of McCaul et al., however, a 2003 study found that employment did not seem to reduce 
adolescent substance use, and, in fact, being employed full time increased prevalence rates for 
heavy drug use, heavy alcohol use, and heavy cigarette smoking (Wu, Schlenger, & Galvin, 
2003). Based on these results, they suggested implementing substance use education and early 
intervention in the workplace for adolescent substance users.  
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Conclusions 
 As mentioned, the ultimate goal of the study was to identify risk factors and combining 
relevant items into a truncated instrument that clinicians could quickly administer and score. 
This, in turn, could improve the chances of a person with numerous risk factors for relapse of 
getting targeted care. After analysis, the constructs that proved to be significant from those four 
sets of variables were used to create an additive scale with the goal of use as a global assessment 
tool for predictors related to a high risk of post-treatment relapse. As stated above, a simple 
additive scale measuring clinical risk factors similar to that of the InDUC or SIP-R could prove 
to be useful for clinicians when trying to identify high risk subjects. A mockup of this instrument 
is included, with an example of a simple 1 and 0 scoring system. Using this scoring system, the 
more questions that a responder answers yes to, the higher the score they would have, indicating 
an increased risk level. Two questions, the current age of the responder and how many 
substances they use in a typical week, had to be included as write in answers out of necessity. 
Results showed that the older a person is, the lower their risk of relapse, so a practitioner could 
expect older clients to be less high risk than younger clients. Also, the results showed that the 
more substances a person used in a week, the higher their risk of relapse was, so practitioners 
could expect someone who reported using more substances to be more high risk than someone 
who used fewer or only one substance in a typical week.  
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Please write in the answers for the first two questions.    
What is your age?    
How many substances do you use in a typical week?    
Please circle either a 1 for Yes or a 0 for No.  Yes No 
Are you a male? 1 0 
Are you currently unemployed? 1 0 
Have you never been married? 1 0 
Have you ever been preoccupied with obtaining/using substances? 1 0 
Have you ever failed to fulfill responsibilities at home, work, or school 
because of your substance use? 
1 0 
Have you ever unsuccessfully tried to reduce or stop your substance use?  1 0 
Have you ever experienced withdrawal symptoms related to your substance 
use? 
1 0 
Have you experienced feelings of craving or a strong urge to use substances? 1 0 
Have you stopped engaging in activities you used to enjoy due to your 
substance use? 
1 0 
Have you ever engaged in intravenous drug use? 1 0 
Have you been treated for any psychiatric disorders in the past (including 
while in substance use treatment)? 
1 0 
Do you have multiple substance specific mental health diagnoses?  1 0 
Before you were 18, were you ever aggressive to other people or animals? 
(this includes deliberate cruelty, physical fights, and menacing with a weapon)  
1 0 
Before you were 18, did you ever deliberately destroy other’s property or 
deliberately set fires? 
1 0 
Before you were 18, did you ever engage in deceitfulness or theft?  1 0 
Before you were 18, did you ever break serious rules, such as staying out at 
night without permission, running away from home overnight at least twice, or 
frequently skipping school? 
1 0 
Have you been arrested within the last year? 1 0 
Have you ever experienced physical abuse? 1 0 
 
This is an example of an attempt to describe and assess for the multitude of risk factors 
that contribute to substance use relapse. This instrument, or one very similar, could be very 
practical in clinical settings. For example, it can have two very different uses, as the instrument 
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could be used on a global basis to look at the general risk of relapse, and on an individual basis 
to deal with specific risk factors identified. Clinically, a provider could look at the overall relapse 
risk score to determine how likely that person is to relapse, and they could also look at specific 
items endorsed to change the duration, intensity, or type of treatment needed for that subject. For 
example, if the subject was high risk and had polysubstance use, then they could benefit from 
treatment that differs from someone who endorsed having been treated or diagnosed with 
depression. Additionally, someone who endorses several of the Behavioral Risk items, which 
showed up as very significantly related to relapse, could benefit from treatment that specifically 
addresses that impulsivity that has been shown to be related to these factors.  
Limitations 
 While this dataset had several unique advantages, there were also significant limitations. 
As discussed previously, data collection was halted in 1995, making the data over fifteen years 
old. Collecting newer data, with updated questions that reflects the changes in diagnostic criteria 
for substance use disorders in the DSM-5, as well as reflecting current trends in substance use, 
could show important differences.  
 In addition, inclusion of more females and more minority subjects could potentially show 
important differences, as past research has shown that gender and race can make a difference in 
substance use, as well as rates of relapse. Gathering more data points would enable future 
researchers to make stronger claims about these hypothesized relationships. Given research on 
diversity of treatment needs among these populations, it is important to look at. 
 The programs may not be reflective of substance use treatment in general because these 
were all programs that were willing to subject themselves to outside evaluation, so they were 
likely more confident that the evaluation was going to reflect positively on them. Facilities that 
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were less confident that the evaluation would reflect positively on their program would 
potentially be less likely to volunteer for the study, skewing the outcomes. The addition of 
programs that may not have the highest success rate could give more generalizable results.  
 On a similar note, only patients who completed treatment and 12 months of follow up 
were included in the study, so the true number of those who relapsed or did not relapse in the 
year following treatment could not be calculated. Similarly, since it has been shown that so few 
of those who need treatment actually receive it, only those who were most able to obtain 
treatment were represented in this study. Future studies could attempt to contact and include 
patients who dropped out of treatment, or did not complete 12 months of follow up using 
alternative methods. Future studies could attempt also to include those who met the criteria for 
needing treatment but were unable to receive treatment for substance use.  
 Finally, access to genetic factors were not available in the CATOR database. Since this 
information was not available, having a family history was instead used to infer that those 
genetic factors were present. Since this is a tenuous connection, being able to actually measure 
genetic factors such as alleles would aid in being able to make more assertive claims.  
Future Considerations 
This research, and the instrument designed, could be used as a starting point that leads to 
research into more individualized treatment. Based on the items endorsed by a patient could 
assist practitioners in creating a more personalized treatment focused on specific problem areas. 
There has already been research in specialized treatment for gender and ethnic groups, as well as 
with specific comorbid disorder, so the addition of the clinical risk factors identified in this study 
could fuel many additional research projects.  
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Furthermore, in their examination of craving and how it fits into the incentive 
sensitization theory, Belin et al. (2013) stated that drug seeking behaviors depend as much on the 
presentation of conditioned reinforcers as the drug itself, which suggests that environmental 
factors such as repeated exposure facilitate the development of incentive habits, which in this 
case would be the habitual use of substances to engage reward systems (Belin et al,, 2013). The 
research demonstrated that administration of specific targeted drugs all reduced instrumental 
drug seeking, decreasing the likelihood of drug taking. This has significant implications for 
future treatments that may prevent relapse as well as promote abstinence, especially when drug-
seeking may be increased by environmental cues. This gap in the research shows there is a need 
for an addition to the current body of research.  
 Additionally, this study suggests that a large number of variables have effects on 
substance use treatment, and those items could be explored in the future with different samples. 
As suggested in the limitations section, using samples featuring primarily women or minorities 
could have very different results from the ones found in this study.  
 Finally, despite the fact that the data could be considered old, the large sample size has 
allowed strong claims to be made about several items that can be examined in future studies.  
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